2 days ago · Age-related macular degeneration (AMD) risk demonstrates a U-shaped association with high density lipoprotein (HDL) levels, in which both low and high cholesterol levels increase the risk for the disorder, according to a cross-sectional study published in Ophthalmology.. Investigators from the University of California, San Diego sourced data for this study from the All of Us research program ...

Nov 1, 2024 · Axial Elongation in Adult Myopia . Regular eye exams are important for all adults, particularly those experiencing myopia progression. During these visits, it is important for clinicians to measure axial length, due to its association with pathologic myopia. 3 An optical biometer can best measure axial length changes, but not all practices have one. . Among optometry practices that do utilize ...

Jan 17, 2025 · Prior to launching perfluorohexyloctane, prescription dry eye treatments were aimed at reducing inflammation and increasing tear production. Even though targeting these areas can be beneficial, they do not specifically address the evaporative component of DED. 5 Perfluorohexyloctane, however, not only treats both the signs and symptoms of dry eye, but targets this element, which previous ...

3 days ago · Topline data were announced from a phase 3 trial demonstrating ONS-5010 (bevacizumab-vikg) was noninferior to ranibizumab at week 12 for the treatment of neovascular age-related macular degeneration (wet AMD).. In August 2023, a Complete Response Letter (CRL) was issued by the Food and Drug Administration (FDA) stating that the original Biologics License Application (BLA) could not be approved ...

Jan 15, 2025 · In the last month, the US Food and Drug Administration (FDA) has approved a visual field analyzer that uses only objective parameters to determine visual field loss, cleared a mapping and data module for a corneal optical coherence tomography (OCT) device, granted rare pediatric disease designation for a novel gene therapy for inherited retinal dystrophy, and approved a generic equivalent for ...

Feb 20, 2024 · Drug Regulatory Updates. PL9643: Dry Eye Disease. Palatin Technologies, Inc. has received confirmation from the FDA regarding the acceptability of the protocols and endpoints for signs and symptoms of PL9643 in its phase 3 pivotal clinical trials for dry eye disease (DED). 1 The remaining phase 3 clinical trials, MELODY-2 and MELODY-3, include endpoints related to both signs and symptoms of ...

Dec 6, 2024 · Eye care professionals have come to understand the importance of not only correcting myopia, but slowing its progression within the last few decades; and while the US Food and Drug Administration (FDA) has approved contact lens therapies for treating the disorder, the agency has yet to approve any myopia control spectacles. Today’s “myopia boom” affects patients worldwide, worsening ...

Oct 4, 2024 · An optometry student can learn a lot in a lab or clinical research setting, but their contact with patients will ultimately guide their clinical decision-making skills and shape their perspectives, according to Andrew Rixon, OD, FAAO, Diplomate (Glaucoma), this year’s recipient of the Vincent Ellerbrock Clinician Educator Award.

May 10, 2024 · Open-angle glaucoma prevalence is projected to rise over the next quarter century, and optometrists, particularly those practicing in states that allow them to perform laser procedures, are finding that selective laser trabeculoplasty (SLT) is gaining first-line treatment status. 1 Although topical ocular hypotensive eye drops have traditionally been used as the preferred initial glaucoma ...

Dec 15, 2023 · Treatments were decided based on the results of this data analysis and patients were monitored every 3 to 6 months for progression, which was defined as 0.25 D or greater myopia spherical equivalent progression (as assessed with cycloplegic autorefraction) or greater than 0.10 mm axial elongation in 6 months. Children who showed progression while on one treatment, received a change in treatment.